Lorcaserin for Cocaine Dependence

This is a 19-week, multi-center, randomized, Phase 2 clinical study comparing the efficacy of lorcaserin (10mg twice daily) to matched placebo in the treatment of cocaine use disorder. Up to 3 weeks will be allowed for the Screening Period and a 13-week treatment phase, with a 3-week follow-up period, with scheduled visits during Study weeks 14 and 16.

Primary Sponsor:
National Institute for Drug Abuse (NIDA)

Prinicipal Investigator:
Debra Bernat, PhD/Public Health/Epidemiology

Contact Phone:

Are you interested in more information on this clinical trial?

First Name *
Last Name *
Email *
Street Address *
City *
State *
Zip Code *
Phone Number 
Verification Code *

Please type what you see (all uppercase):